Global Gastrointestinal Stromal Tumor (GIST) Drug Market Growth 2022-2028
The report requires updating with new data and is sent in 48 hours after order is placed.
As the global economy mends, the 2021 growth of Gastrointestinal Stromal Tumor (GIST) Drug will have significant change from previous year. According to our (LP Information) latest study, the global Gastrointestinal Stromal Tumor (GIST) Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Gastrointestinal Stromal Tumor (GIST) Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Gastrointestinal Stromal Tumor (GIST) Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gastrointestinal Stromal Tumor (GIST) Drug market, reaching US$ million by the year 2028. As for the Europe Gastrointestinal Stromal Tumor (GIST) Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gastrointestinal Stromal Tumor (GIST) Drug players cover Ariad Pharmaceuticals, Inc., Arog Pharmaceuticals, Inc., Array BioPharma Inc., and Astex Pharmaceuticals, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Stromal Tumor (GIST) Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
As the global economy mends, the 2021 growth of Gastrointestinal Stromal Tumor (GIST) Drug will have significant change from previous year. According to our (LP Information) latest study, the global Gastrointestinal Stromal Tumor (GIST) Drug market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Gastrointestinal Stromal Tumor (GIST) Drug market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Gastrointestinal Stromal Tumor (GIST) Drug market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Gastrointestinal Stromal Tumor (GIST) Drug market, reaching US$ million by the year 2028. As for the Europe Gastrointestinal Stromal Tumor (GIST) Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Gastrointestinal Stromal Tumor (GIST) Drug players cover Ariad Pharmaceuticals, Inc., Arog Pharmaceuticals, Inc., Array BioPharma Inc., and Astex Pharmaceuticals, Inc., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Stromal Tumor (GIST) Drug market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
- Amcasertib
- Anagrelide hydrochloride CR
- APG-1351
- Binimetinib
- Others
- Clinic
- Hospital
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Ariad Pharmaceuticals, Inc.
- Arog Pharmaceuticals, Inc.
- Array BioPharma Inc.
- Astex Pharmaceuticals, Inc.
- Blueprint Medicines Corporation
- Boston Biomedical, Inc.
- Calithera Biosciences, Inc.
- Chipscreen Biosciences Ltd
- Deciphera Pharmaceuticals, LLC
- F. Hoffmann-La Roche Ltd.
- Horizon Pharma Plc
- Immunicum AB
- Jiangsu Hengrui Medicine Co., Ltd.
- Kolltan Pharmaceuticals, Inc.
- Natco Pharma Limited
- Nerviano Medical Sciences S.r.l.
- Novartis AG
- Omeros Corporation
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Gastrointestinal Stromal Tumor (GIST) Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Gastrointestinal Stromal Tumor (GIST) Drug by Country/Region, 2017, 2022 & 2028
2.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type
2.2.1 Amcasertib
2.2.2 Anagrelide hydrochloride CR
2.2.3 APG-1351
2.2.4 Binimetinib
2.2.5 Others
2.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
2.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Type (2017-2022)
2.4 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Others
2.5 Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
2.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Application (2017-2022)
3 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG BY COMPANY
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Company
3.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales by Company (2020-2022)
3.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2020-2022)
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2020-2022)
3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2020-2022)
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Company
3.4 Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Location Distribution
3.4.2 Players Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG BY GEOGRAPHIC REGION
4.1 World Historic Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue by Geographic Region
4.2 World Historic Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue by Country/Region
4.3 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth
4.4 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth
4.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth
4.6 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth
5 AMERICAS
5.1 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
5.1.1 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022)
5.1.2 Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022)
5.2 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
5.3 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
6.1.1 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2022)
6.1.2 APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2022)
6.2 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
6.3 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug by Country
7.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022)
7.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022)
7.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
7.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.1.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
8.3 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
10.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
10.4 Industry Chain Structure of Gastrointestinal Stromal Tumor (GIST) Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
11.3 Gastrointestinal Stromal Tumor (GIST) Drug Customer
12 WORLD FORECAST REVIEW FOR GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG BY GEOGRAPHIC REGION
12.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Region
12.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Region (2023-2028)
12.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Type
12.7 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ariad Pharmaceuticals, Inc.
13.1.1 Ariad Pharmaceuticals, Inc. Company Information
13.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Ariad Pharmaceuticals, Inc. Main Business Overview
13.1.5 Ariad Pharmaceuticals, Inc. Latest Developments
13.2 Arog Pharmaceuticals, Inc.
13.2.1 Arog Pharmaceuticals, Inc. Company Information
13.2.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Arog Pharmaceuticals, Inc. Main Business Overview
13.2.5 Arog Pharmaceuticals, Inc. Latest Developments
13.3 Array BioPharma Inc.
13.3.1 Array BioPharma Inc. Company Information
13.3.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Array BioPharma Inc. Main Business Overview
13.3.5 Array BioPharma Inc. Latest Developments
13.4 Astex Pharmaceuticals, Inc.
13.4.1 Astex Pharmaceuticals, Inc. Company Information
13.4.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Astex Pharmaceuticals, Inc. Main Business Overview
13.4.5 Astex Pharmaceuticals, Inc. Latest Developments
13.5 Blueprint Medicines Corporation
13.5.1 Blueprint Medicines Corporation Company Information
13.5.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Blueprint Medicines Corporation Main Business Overview
13.5.5 Blueprint Medicines Corporation Latest Developments
13.6 Boston Biomedical, Inc.
13.6.1 Boston Biomedical, Inc. Company Information
13.6.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Boston Biomedical, Inc. Main Business Overview
13.6.5 Boston Biomedical, Inc. Latest Developments
13.7 Calithera Biosciences, Inc.
13.7.1 Calithera Biosciences, Inc. Company Information
13.7.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Calithera Biosciences, Inc. Main Business Overview
13.7.5 Calithera Biosciences, Inc. Latest Developments
13.8 Chipscreen Biosciences Ltd
13.8.1 Chipscreen Biosciences Ltd Company Information
13.8.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Chipscreen Biosciences Ltd Main Business Overview
13.8.5 Chipscreen Biosciences Ltd Latest Developments
13.9 Deciphera Pharmaceuticals, LLC
13.9.1 Deciphera Pharmaceuticals, LLC Company Information
13.9.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Deciphera Pharmaceuticals, LLC Main Business Overview
13.9.5 Deciphera Pharmaceuticals, LLC Latest Developments
13.10 F. Hoffmann-La Roche Ltd.
13.10.1 F. Hoffmann-La Roche Ltd. Company Information
13.10.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.10.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.11 Horizon Pharma Plc
13.11.1 Horizon Pharma Plc Company Information
13.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Horizon Pharma Plc Main Business Overview
13.11.5 Horizon Pharma Plc Latest Developments
13.12 Immunicum AB
13.12.1 Immunicum AB Company Information
13.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Immunicum AB Main Business Overview
13.12.5 Immunicum AB Latest Developments
13.13 Jiangsu Hengrui Medicine Co., Ltd.
13.13.1 Jiangsu Hengrui Medicine Co., Ltd. Company Information
13.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Jiangsu Hengrui Medicine Co., Ltd. Main Business Overview
13.13.5 Jiangsu Hengrui Medicine Co., Ltd. Latest Developments
13.14 Kolltan Pharmaceuticals, Inc.
13.14.1 Kolltan Pharmaceuticals, Inc. Company Information
13.14.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Kolltan Pharmaceuticals, Inc. Main Business Overview
13.14.5 Kolltan Pharmaceuticals, Inc. Latest Developments
13.15 Natco Pharma Limited
13.15.1 Natco Pharma Limited Company Information
13.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Natco Pharma Limited Main Business Overview
13.15.5 Natco Pharma Limited Latest Developments
13.16 Nerviano Medical Sciences S.r.l.
13.16.1 Nerviano Medical Sciences S.r.l. Company Information
13.16.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Nerviano Medical Sciences S.r.l. Main Business Overview
13.16.5 Nerviano Medical Sciences S.r.l. Latest Developments
13.17 Novartis AG
13.17.1 Novartis AG Company Information
13.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Novartis AG Main Business Overview
13.17.5 Novartis AG Latest Developments
13.18 Omeros Corporation
13.18.1 Omeros Corporation Company Information
13.18.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Omeros Corporation Main Business Overview
13.18.5 Omeros Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Gastrointestinal Stromal Tumor (GIST) Drug by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Gastrointestinal Stromal Tumor (GIST) Drug by Country/Region, 2017, 2022 & 2028
2.2 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Type
2.2.1 Amcasertib
2.2.2 Anagrelide hydrochloride CR
2.2.3 APG-1351
2.2.4 Binimetinib
2.2.5 Others
2.3 Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
2.3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
2.3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Type (2017-2022)
2.3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Type (2017-2022)
2.4 Gastrointestinal Stromal Tumor (GIST) Drug Segment by Application
2.4.1 Clinic
2.4.2 Hospital
2.4.3 Others
2.5 Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
2.5.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Market Share by Application (2017-2022)
2.5.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue and Market Share by Application (2017-2022)
2.5.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Application (2017-2022)
3 GLOBAL GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG BY COMPANY
3.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Breakdown Data by Company
3.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales by Company (2020-2022)
3.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2020-2022)
3.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue by Company (2020-2022)
3.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2020-2022)
3.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2020-2022)
3.3 Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Company
3.4 Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Product Location Distribution
3.4.2 Players Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG BY GEOGRAPHIC REGION
4.1 World Historic Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Geographic Region (2017-2022)
4.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue by Geographic Region
4.2 World Historic Gastrointestinal Stromal Tumor (GIST) Drug Market Size by Country/Region (2017-2022)
4.2.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales by Country/Region (2017-2022)
4.2.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue by Country/Region
4.3 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth
4.4 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth
4.5 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth
4.6 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth
5 AMERICAS
5.1 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country
5.1.1 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022)
5.1.2 Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022)
5.2 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
5.3 Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region
6.1.1 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2022)
6.1.2 APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2022)
6.2 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
6.3 APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug by Country
7.1.1 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022)
7.1.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022)
7.2 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
7.3 Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug by Country
8.1.1 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022)
8.1.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022)
8.2 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type
8.3 Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
10.3 Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
10.4 Industry Chain Structure of Gastrointestinal Stromal Tumor (GIST) Drug
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Gastrointestinal Stromal Tumor (GIST) Drug Distributors
11.3 Gastrointestinal Stromal Tumor (GIST) Drug Customer
12 WORLD FORECAST REVIEW FOR GASTROINTESTINAL STROMAL TUMOR (GIST) DRUG BY GEOGRAPHIC REGION
12.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Market Size Forecast by Region
12.1.1 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Region (2023-2028)
12.1.2 Global Gastrointestinal Stromal Tumor (GIST) Drug Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Type
12.7 Global Gastrointestinal Stromal Tumor (GIST) Drug Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Ariad Pharmaceuticals, Inc.
13.1.1 Ariad Pharmaceuticals, Inc. Company Information
13.1.2 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.1.3 Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Ariad Pharmaceuticals, Inc. Main Business Overview
13.1.5 Ariad Pharmaceuticals, Inc. Latest Developments
13.2 Arog Pharmaceuticals, Inc.
13.2.1 Arog Pharmaceuticals, Inc. Company Information
13.2.2 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.2.3 Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Arog Pharmaceuticals, Inc. Main Business Overview
13.2.5 Arog Pharmaceuticals, Inc. Latest Developments
13.3 Array BioPharma Inc.
13.3.1 Array BioPharma Inc. Company Information
13.3.2 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.3.3 Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Array BioPharma Inc. Main Business Overview
13.3.5 Array BioPharma Inc. Latest Developments
13.4 Astex Pharmaceuticals, Inc.
13.4.1 Astex Pharmaceuticals, Inc. Company Information
13.4.2 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.4.3 Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Astex Pharmaceuticals, Inc. Main Business Overview
13.4.5 Astex Pharmaceuticals, Inc. Latest Developments
13.5 Blueprint Medicines Corporation
13.5.1 Blueprint Medicines Corporation Company Information
13.5.2 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.5.3 Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Blueprint Medicines Corporation Main Business Overview
13.5.5 Blueprint Medicines Corporation Latest Developments
13.6 Boston Biomedical, Inc.
13.6.1 Boston Biomedical, Inc. Company Information
13.6.2 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.6.3 Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Boston Biomedical, Inc. Main Business Overview
13.6.5 Boston Biomedical, Inc. Latest Developments
13.7 Calithera Biosciences, Inc.
13.7.1 Calithera Biosciences, Inc. Company Information
13.7.2 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.7.3 Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Calithera Biosciences, Inc. Main Business Overview
13.7.5 Calithera Biosciences, Inc. Latest Developments
13.8 Chipscreen Biosciences Ltd
13.8.1 Chipscreen Biosciences Ltd Company Information
13.8.2 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.8.3 Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Chipscreen Biosciences Ltd Main Business Overview
13.8.5 Chipscreen Biosciences Ltd Latest Developments
13.9 Deciphera Pharmaceuticals, LLC
13.9.1 Deciphera Pharmaceuticals, LLC Company Information
13.9.2 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.9.3 Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Deciphera Pharmaceuticals, LLC Main Business Overview
13.9.5 Deciphera Pharmaceuticals, LLC Latest Developments
13.10 F. Hoffmann-La Roche Ltd.
13.10.1 F. Hoffmann-La Roche Ltd. Company Information
13.10.2 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.10.3 F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 F. Hoffmann-La Roche Ltd. Main Business Overview
13.10.5 F. Hoffmann-La Roche Ltd. Latest Developments
13.11 Horizon Pharma Plc
13.11.1 Horizon Pharma Plc Company Information
13.11.2 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.11.3 Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Horizon Pharma Plc Main Business Overview
13.11.5 Horizon Pharma Plc Latest Developments
13.12 Immunicum AB
13.12.1 Immunicum AB Company Information
13.12.2 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.12.3 Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Immunicum AB Main Business Overview
13.12.5 Immunicum AB Latest Developments
13.13 Jiangsu Hengrui Medicine Co., Ltd.
13.13.1 Jiangsu Hengrui Medicine Co., Ltd. Company Information
13.13.2 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.13.3 Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Jiangsu Hengrui Medicine Co., Ltd. Main Business Overview
13.13.5 Jiangsu Hengrui Medicine Co., Ltd. Latest Developments
13.14 Kolltan Pharmaceuticals, Inc.
13.14.1 Kolltan Pharmaceuticals, Inc. Company Information
13.14.2 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.14.3 Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 Kolltan Pharmaceuticals, Inc. Main Business Overview
13.14.5 Kolltan Pharmaceuticals, Inc. Latest Developments
13.15 Natco Pharma Limited
13.15.1 Natco Pharma Limited Company Information
13.15.2 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.15.3 Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Natco Pharma Limited Main Business Overview
13.15.5 Natco Pharma Limited Latest Developments
13.16 Nerviano Medical Sciences S.r.l.
13.16.1 Nerviano Medical Sciences S.r.l. Company Information
13.16.2 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.16.3 Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Nerviano Medical Sciences S.r.l. Main Business Overview
13.16.5 Nerviano Medical Sciences S.r.l. Latest Developments
13.17 Novartis AG
13.17.1 Novartis AG Company Information
13.17.2 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.17.3 Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Novartis AG Main Business Overview
13.17.5 Novartis AG Latest Developments
13.18 Omeros Corporation
13.18.1 Omeros Corporation Company Information
13.18.2 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
13.18.3 Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 Omeros Corporation Main Business Overview
13.18.5 Omeros Corporation Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Amcasertib
Table 4. Major Players of Anagrelide hydrochloride CR
Table 5. Major Players of APG-1351
Table 6. Major Players of Binimetinib
Table 7. Major Players of Others
Table 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
Table 10. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2022) & ($ million)
Table 11. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2022)
Table 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Table 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2022)
Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2017-2022)
Table 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2020-2022)
Table 20. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2020-2022)
Table 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Producing Area Distribution and Sales Area
Table 24. Players Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
Table 25. Gastrointestinal Stromal Tumor (GIST) Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Geographic Region (2017-2022)
Table 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country/Region (2017-2022)
Table 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)
Table 38. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)
Table 40. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
Table 42. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Table 44. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2017-2022)
Table 46. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2017-2022)
Table 48. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
Table 50. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Table 52. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)
Table 54. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)
Table 56. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
Table 58. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Gastrointestinal Stromal Tumor (GIST) Drug
Table 69. Key Market Challenges & Risks of Gastrointestinal Stromal Tumor (GIST) Drug
Table 70. Key Industry Trends of Gastrointestinal Stromal Tumor (GIST) Drug
Table 71. Gastrointestinal Stromal Tumor (GIST) Drug Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table 74. Gastrointestinal Stromal Tumor (GIST) Drug Customer List
Table 75. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Forecast by Region
Table 77. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Application (2023-2028)
Table 95. Ariad Pharmaceuticals, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 97. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Ariad Pharmaceuticals, Inc. Main Business
Table 99. Ariad Pharmaceuticals, Inc. Latest Developments
Table 100. Arog Pharmaceuticals, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 102. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Arog Pharmaceuticals, Inc. Main Business
Table 104. Arog Pharmaceuticals, Inc. Latest Developments
Table 105. Array BioPharma Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 107. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Array BioPharma Inc. Main Business
Table 109. Array BioPharma Inc. Latest Developments
Table 110. Astex Pharmaceuticals, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 112. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Astex Pharmaceuticals, Inc. Main Business
Table 114. Astex Pharmaceuticals, Inc. Latest Developments
Table 115. Blueprint Medicines Corporation Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 117. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Blueprint Medicines Corporation Main Business
Table 119. Blueprint Medicines Corporation Latest Developments
Table 120. Boston Biomedical, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 122. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Boston Biomedical, Inc. Main Business
Table 124. Boston Biomedical, Inc. Latest Developments
Table 125. Calithera Biosciences, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 127. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Calithera Biosciences, Inc. Main Business
Table 129. Calithera Biosciences, Inc. Latest Developments
Table 130. Chipscreen Biosciences Ltd Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 132. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Chipscreen Biosciences Ltd Main Business
Table 134. Chipscreen Biosciences Ltd Latest Developments
Table 135. Deciphera Pharmaceuticals, LLC Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 137. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Deciphera Pharmaceuticals, LLC Main Business
Table 139. Deciphera Pharmaceuticals, LLC Latest Developments
Table 140. F. Hoffmann-La Roche Ltd. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 141. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 142. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. F. Hoffmann-La Roche Ltd. Main Business
Table 144. F. Hoffmann-La Roche Ltd. Latest Developments
Table 145. Horizon Pharma Plc Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 146. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 147. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 148. Horizon Pharma Plc Main Business
Table 149. Horizon Pharma Plc Latest Developments
Table 150. Immunicum AB Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 151. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 152. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 153. Immunicum AB Main Business
Table 154. Immunicum AB Latest Developments
Table 155. Jiangsu Hengrui Medicine Co., Ltd. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 156. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 157. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 158. Jiangsu Hengrui Medicine Co., Ltd. Main Business
Table 159. Jiangsu Hengrui Medicine Co., Ltd. Latest Developments
Table 160. Kolltan Pharmaceuticals, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 161. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 162. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 163. Kolltan Pharmaceuticals, Inc. Main Business
Table 164. Kolltan Pharmaceuticals, Inc. Latest Developments
Table 165. Natco Pharma Limited Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 166. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 167. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 168. Natco Pharma Limited Main Business
Table 169. Natco Pharma Limited Latest Developments
Table 170. Nerviano Medical Sciences S.r.l. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 171. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 172. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 173. Nerviano Medical Sciences S.r.l. Main Business
Table 174. Nerviano Medical Sciences S.r.l. Latest Developments
Table 175. Novartis AG Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 176. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 177. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 178. Novartis AG Main Business
Table 179. Novartis AG Latest Developments
Table 180. Omeros Corporation Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 181. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 182. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 183. Omeros Corporation Main Business
Table 184. Omeros Corporation Latest Developments
Table 1. Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Gastrointestinal Stromal Tumor (GIST) Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Amcasertib
Table 4. Major Players of Anagrelide hydrochloride CR
Table 5. Major Players of APG-1351
Table 6. Major Players of Binimetinib
Table 7. Major Players of Others
Table 8. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
Table 9. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
Table 10. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Type (2017-2022) & ($ million)
Table 11. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2022)
Table 12. Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Type (2017-2022) & (USD/Pcs)
Table 13. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
Table 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Table 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Application (2017-2022)
Table 16. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application (2017-2022)
Table 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Application (2017-2022) & (USD/Pcs)
Table 18. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Company (2020-2022) & (K Pcs)
Table 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Company (2020-2022)
Table 20. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Company (2020-2022) ($ Millions)
Table 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company (2020-2022)
Table 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Sale Price by Company (2020-2022) & (USD/Pcs)
Table 23. Key Manufacturers Gastrointestinal Stromal Tumor (GIST) Drug Producing Area Distribution and Sales Area
Table 24. Players Gastrointestinal Stromal Tumor (GIST) Drug Products Offered
Table 25. Gastrointestinal Stromal Tumor (GIST) Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Geographic Region (2017-2022) & (K Pcs)
Table 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Geographic Region (2017-2022)
Table 30. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Geographic Region (2017-2022) & ($ millions)
Table 31. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Geographic Region (2017-2022)
Table 32. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country/Region (2017-2022) & (K Pcs)
Table 33. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country/Region (2017-2022)
Table 34. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country/Region (2017-2022) & ($ millions)
Table 35. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country/Region (2017-2022)
Table 36. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
Table 37. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)
Table 38. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & ($ Millions)
Table 39. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)
Table 40. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
Table 41. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
Table 42. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
Table 43. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Table 44. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2017-2022) & (K Pcs)
Table 45. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2017-2022)
Table 46. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Region (2017-2022) & ($ Millions)
Table 47. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Region (2017-2022)
Table 48. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
Table 49. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
Table 50. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
Table 51. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Table 52. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
Table 53. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)
Table 54. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & ($ Millions)
Table 55. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)
Table 56. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
Table 57. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
Table 58. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
Table 59. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Table 60. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Country (2017-2022) & (K Pcs)
Table 61. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country (2017-2022)
Table 62. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue by Country (2017-2022) & ($ Millions)
Table 63. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country (2017-2022)
Table 64. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Type (2017-2022) & (K Pcs)
Table 65. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type (2017-2022)
Table 66. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales by Application (2017-2022) & (K Pcs)
Table 67. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Table 68. Key Market Drivers & Growth Opportunities of Gastrointestinal Stromal Tumor (GIST) Drug
Table 69. Key Market Challenges & Risks of Gastrointestinal Stromal Tumor (GIST) Drug
Table 70. Key Industry Trends of Gastrointestinal Stromal Tumor (GIST) Drug
Table 71. Gastrointestinal Stromal Tumor (GIST) Drug Raw Material
Table 72. Key Suppliers of Raw Materials
Table 73. Gastrointestinal Stromal Tumor (GIST) Drug Distributors List
Table 74. Gastrointestinal Stromal Tumor (GIST) Drug Customer List
Table 75. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 76. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Forecast by Region
Table 77. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 78. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Region (2023-2028)
Table 79. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 80. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 81. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Region (2023-2028) & (K Pcs)
Table 82. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Region (2023-2028) & ($ millions)
Table 83. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 84. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Country (2023-2028) & (K Pcs)
Table 86. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Country (2023-2028) & ($ millions)
Table 87. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Type (2023-2028) & (K Pcs)
Table 88. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Type (2023-2028)
Table 89. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 90. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Type (2023-2028)
Table 91. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Forecast by Application (2023-2028) & (K Pcs)
Table 92. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share Forecast by Application (2023-2028)
Table 93. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 94. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share Forecast by Application (2023-2028)
Table 95. Ariad Pharmaceuticals, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 96. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 97. Ariad Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 98. Ariad Pharmaceuticals, Inc. Main Business
Table 99. Ariad Pharmaceuticals, Inc. Latest Developments
Table 100. Arog Pharmaceuticals, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 101. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 102. Arog Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 103. Arog Pharmaceuticals, Inc. Main Business
Table 104. Arog Pharmaceuticals, Inc. Latest Developments
Table 105. Array BioPharma Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 106. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 107. Array BioPharma Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 108. Array BioPharma Inc. Main Business
Table 109. Array BioPharma Inc. Latest Developments
Table 110. Astex Pharmaceuticals, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 111. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 112. Astex Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 113. Astex Pharmaceuticals, Inc. Main Business
Table 114. Astex Pharmaceuticals, Inc. Latest Developments
Table 115. Blueprint Medicines Corporation Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 116. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 117. Blueprint Medicines Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 118. Blueprint Medicines Corporation Main Business
Table 119. Blueprint Medicines Corporation Latest Developments
Table 120. Boston Biomedical, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 121. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 122. Boston Biomedical, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 123. Boston Biomedical, Inc. Main Business
Table 124. Boston Biomedical, Inc. Latest Developments
Table 125. Calithera Biosciences, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 126. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 127. Calithera Biosciences, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 128. Calithera Biosciences, Inc. Main Business
Table 129. Calithera Biosciences, Inc. Latest Developments
Table 130. Chipscreen Biosciences Ltd Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 131. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 132. Chipscreen Biosciences Ltd Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 133. Chipscreen Biosciences Ltd Main Business
Table 134. Chipscreen Biosciences Ltd Latest Developments
Table 135. Deciphera Pharmaceuticals, LLC Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 136. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 137. Deciphera Pharmaceuticals, LLC Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 138. Deciphera Pharmaceuticals, LLC Main Business
Table 139. Deciphera Pharmaceuticals, LLC Latest Developments
Table 140. F. Hoffmann-La Roche Ltd. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 141. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 142. F. Hoffmann-La Roche Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 143. F. Hoffmann-La Roche Ltd. Main Business
Table 144. F. Hoffmann-La Roche Ltd. Latest Developments
Table 145. Horizon Pharma Plc Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 146. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 147. Horizon Pharma Plc Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 148. Horizon Pharma Plc Main Business
Table 149. Horizon Pharma Plc Latest Developments
Table 150. Immunicum AB Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 151. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 152. Immunicum AB Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 153. Immunicum AB Main Business
Table 154. Immunicum AB Latest Developments
Table 155. Jiangsu Hengrui Medicine Co., Ltd. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 156. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 157. Jiangsu Hengrui Medicine Co., Ltd. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 158. Jiangsu Hengrui Medicine Co., Ltd. Main Business
Table 159. Jiangsu Hengrui Medicine Co., Ltd. Latest Developments
Table 160. Kolltan Pharmaceuticals, Inc. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 161. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 162. Kolltan Pharmaceuticals, Inc. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 163. Kolltan Pharmaceuticals, Inc. Main Business
Table 164. Kolltan Pharmaceuticals, Inc. Latest Developments
Table 165. Natco Pharma Limited Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 166. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 167. Natco Pharma Limited Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 168. Natco Pharma Limited Main Business
Table 169. Natco Pharma Limited Latest Developments
Table 170. Nerviano Medical Sciences S.r.l. Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 171. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 172. Nerviano Medical Sciences S.r.l. Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 173. Nerviano Medical Sciences S.r.l. Main Business
Table 174. Nerviano Medical Sciences S.r.l. Latest Developments
Table 175. Novartis AG Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 176. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 177. Novartis AG Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 178. Novartis AG Main Business
Table 179. Novartis AG Latest Developments
Table 180. Omeros Corporation Basic Information, Gastrointestinal Stromal Tumor (GIST) Drug Manufacturing Base, Sales Area and Its Competitors
Table 181. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Product Offered
Table 182. Omeros Corporation Gastrointestinal Stromal Tumor (GIST) Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
Table 183. Omeros Corporation Main Business
Table 184. Omeros Corporation Latest Developments
LIST OF FIGURES
Figure 1. Picture of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 2. Gastrointestinal Stromal Tumor (GIST) Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Amcasertib
Figure 10. Product Picture of Anagrelide hydrochloride CR
Figure 11. Product Picture of APG-1351
Figure 12. Product Picture of Binimetinib
Figure 13. Product Picture of Others
Figure 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2021
Figure 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2022)
Figure 16. Gastrointestinal Stromal Tumor (GIST) Drug Consumed in Clinic
Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 18. Gastrointestinal Stromal Tumor (GIST) Drug Consumed in Hospital
Figure 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 20. Gastrointestinal Stromal Tumor (GIST) Drug Consumed in Others
Figure 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Others (2017-2022) & (K Pcs)
Figure 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Figure 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application in 2021
Figure 24. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company in 2021
Figure 26. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Geographic Region in 2021
Figure 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2017-2022)
Figure 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country/Region in 2021
Figure 30. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2022 (K Pcs)
Figure 31. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2022 ($ Millions)
Figure 32. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2022 (K Pcs)
Figure 33. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2022 ($ Millions)
Figure 34. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2022 (K Pcs)
Figure 35. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2022 (K Pcs)
Figure 37. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2022 ($ Millions)
Figure 38. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2021
Figure 39. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country in 2021
Figure 40. United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region in 2021
Figure 45. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions in 2021
Figure 46. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2021
Figure 53. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country in 2021
Figure 54. Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country in 2021
Figure 61. Egypt Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in 2021
Figure 67. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 68. Industry Chain Structure of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 1. Picture of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 2. Gastrointestinal Stromal Tumor (GIST) Drug Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Growth Rate 2017-2028 (K Pcs)
Figure 7. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Gastrointestinal Stromal Tumor (GIST) Drug Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Amcasertib
Figure 10. Product Picture of Anagrelide hydrochloride CR
Figure 11. Product Picture of APG-1351
Figure 12. Product Picture of Binimetinib
Figure 13. Product Picture of Others
Figure 14. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Type in 2021
Figure 15. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Type (2017-2022)
Figure 16. Gastrointestinal Stromal Tumor (GIST) Drug Consumed in Clinic
Figure 17. Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Clinic (2017-2022) & (K Pcs)
Figure 18. Gastrointestinal Stromal Tumor (GIST) Drug Consumed in Hospital
Figure 19. Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Hospital (2017-2022) & (K Pcs)
Figure 20. Gastrointestinal Stromal Tumor (GIST) Drug Consumed in Others
Figure 21. Global Gastrointestinal Stromal Tumor (GIST) Drug Market: Others (2017-2022) & (K Pcs)
Figure 22. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Application (2017-2022)
Figure 23. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Application in 2021
Figure 24. Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market by Company in 2021 ($ Million)
Figure 25. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Company in 2021
Figure 26. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Geographic Region (2017-2022)
Figure 27. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Geographic Region in 2021
Figure 28. Global Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region (2017-2022)
Figure 29. Global Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country/Region in 2021
Figure 30. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2022 (K Pcs)
Figure 31. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2022 ($ Millions)
Figure 32. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2022 (K Pcs)
Figure 33. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2022 ($ Millions)
Figure 34. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2022 (K Pcs)
Figure 35. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2022 ($ Millions)
Figure 36. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales 2017-2022 (K Pcs)
Figure 37. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue 2017-2022 ($ Millions)
Figure 38. Americas Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2021
Figure 39. Americas Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country in 2021
Figure 40. United States Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 41. Canada Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 42. Mexico Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 43. Brazil Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 44. APAC Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Region in 2021
Figure 45. APAC Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Regions in 2021
Figure 46. China Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 47. Japan Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 48. South Korea Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 49. Southeast Asia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 50. India Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 51. Australia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 52. Europe Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2021
Figure 53. Europe Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country in 2021
Figure 54. Germany Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 55. France Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 56. UK Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 57. Italy Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 58. Russia Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 59. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Sales Market Share by Country in 2021
Figure 60. Middle East & Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Market Share by Country in 2021
Figure 61. Egypt Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 62. South Africa Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 63. Israel Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 64. Turkey Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 65. GCC Country Gastrointestinal Stromal Tumor (GIST) Drug Revenue Growth 2017-2022 ($ Millions)
Figure 66. Manufacturing Cost Structure Analysis of Gastrointestinal Stromal Tumor (GIST) Drug in 2021
Figure 67. Manufacturing Process Analysis of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 68. Industry Chain Structure of Gastrointestinal Stromal Tumor (GIST) Drug
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
